Spinal Muscular Atrophy (SMA) affects 1 in 10,000 infants and results in progressive loss of mobility, respiratory complications, muscle weakness and atrophy, as well as challenges swallowing and eating. SMA is also the leading genetic cause of infant death worldwide.
Ayansh Madan has the most lethal form of SMA disease type, which claims the lives of most patients by age 2. If not treated, the life span of infants with SMA Type varies up to 1 or 2 years depending on the progression.
Zolgensma Gene Therapy is a potential cure for SMA for children below two years of age and it has to be imported from the USA. Ayansh Madan needs Zolgensma gene therapy as soon as possible to save his life.
Donate whatever you can with your kind heart to save Ayansh Madan's life. Please follow and share his story on social media handles and help us receive possible funds to proceed with his treatments
Spread the word:
Recently, we have been observing more and more SMA cases are visible due to developments in life-saving therapies and medicines. Spreading the word on diagnoses and about the disease could save a few more lives.
#SMA #CureSMA #spinalmascularatrophy
Ayansh Madan has only now 4 months to collect funds for the desired treatment. We request you to help in raising funds for Ayansh's treatment and give him a chance to live healthily.
Please share, support & contribute as much as possible. Nothing is small or big. Every penny counts. Thank you all in advance.